We found significant SOX17 immunoreactivity in TECs in CD8‐positive T‐cell‐rich stroma than in CD8‐positive T‐cell‐poor stroma without association with TLS (Figures 2 and 3). The gene discussed is CD8A; the disease is Tumor Lysis Syndrome.